New Data Shows Addition of BeyondSpring’s Plinabulin Reverses Neulasta’s Potential Immune-Suppressive Phenotype in Treating Chemotherapy-Induced Neutropenia February 26, 2019 - NASDAQ Companies 0 » View More News for February 26, 2019